StreetInsider.com News Articles

Abivax (ABVX) PT Raised to $175 at Piper Sandler

Thu, 09 Jul 2026 07:11:06 -0400

Piper Sandler analyst Allison M. Bratzel raised the price target on Abivax (NASDAQ: ABVX) to $175.00 (from $165.00) while maintaining a Overweight rating.

Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I

Mon, 06 Jul 2026 21:36:00 -0400

si-local-file:///var/storage/secattach/20260706/26737231.html

Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I

Mon, 06 Jul 2026 21:36:00 -0400

si-local-file:///var/storage/secattach/20260706/26737231.html

Form SCHEDULE 13D/A Abivax S.A. Filed by: Sofinnova Crossover I

Mon, 06 Jul 2026 21:36:00 -0400

si-local-file:///var/storage/secattach/20260706/26737231.html

Form 6-K Abivax S.A. For: Jul 02

Thu, 02 Jul 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260702/26727770.html

Form 6-K Abivax S.A. For: Jul 02

Thu, 02 Jul 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260702/26727770.html

Form 6-K Abivax S.A. For: Jul 02

Thu, 02 Jul 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260702/26727770.html

Form 424B5 Abivax S.A.

Thu, 02 Jul 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260702/26727626.html

Form 424B5 Abivax S.A.

Thu, 02 Jul 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260702/26727626.html

Form 424B5 Abivax S.A.

Thu, 02 Jul 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260702/26727626.html

Abivax (ABVX) PT Raised to $155 at Truist Securities

Thu, 02 Jul 2026 11:53:22 -0400

(Updated - July 2, 2026 11:53 AM EDT)

Truist Securities analyst Greg Renza raised the price target on Abivax (NASDAQ: ABVX) to $155.00 (from $135.00) while maintaining a Buy rating.

The analyst commented: "Digesting Part 2 Data Ahead of Regulatory Next Steps, Layers of Confidence Building; Off the back of maintenance Part 2 data, we spoke with ABVX mgmt to get the latest views on the setup for obe' into the 4Q submission in UC, the opportunity set ahead spanning the end-market, combinability, Crohn's, and strategic business activity. We continue to view the Part 2 data as easing the looming safety question

Abivax (ABVX) PT Raised to $155 at Truist Securities

Thu, 02 Jul 2026 11:53:22 -0400

(Updated - July 2, 2026 11:53 AM EDT)

Truist Securities analyst Greg Renza raised the price target on Abivax (NASDAQ: ABVX) to $155.00 (from $135.00) while maintaining a Buy rating.

Abivax jumps as fully exercised option lifts share-sale haul to $920 million

Thu, 02 Jul 2026 06:01:04 -0400

Investing.com -- Shares of Abivax rose after the French biotechnology company said underwriters had fully exercised their option to purchase additional American depositary shares (ADS), pushing gross proceeds from its recent offering to $920 million, up from the $800 million raised a day earlier.

The company said a total of 7.36 million ADSs were issued in the offering, generating gross proceeds of $920 million, or €807 million, and net proceeds of $874.1 million.

Abivax’s Nasdaq-listed shares jumped 6.7% in premarket trading by 03:51 ET (07:51 GMT). Paris-listed shares rose 5.9%.

The additional ADSs are expected to be delivered when the offering closes on July

Jefferies upgrades Abivax to Buy, lifts PT as safety concerns over obefazimod ease

Wed, 01 Jul 2026 11:53:26 -0400

Investing.com -- Jefferies upgraded Abivax to "Buy" from "Hold" and raised its price target to $158 from $108 after updated Phase 3 data for its lead drug candidate, obefazimod, alleviated concerns over previously reported malignancy cases and reinforced confidence in the therapy's efficacy.

The upgrade reverses Jefferies' cautious stance adopted earlier this month, with the brokerage saying the latest ABTECT Part 2 update removed a key overhang on the stock. It said management's explanation of the safety data and continued improvements in efficacy strengthened the investment case, although risks around financing, commercialization and regulatory execution remain.

Jefferies

Form FWP Abivax S.A. Filed by: Abivax S.A.

Wed, 01 Jul 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20260701/26717996.html

Form FWP Abivax S.A. Filed by: Abivax S.A.

Wed, 01 Jul 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20260701/26717996.html

Form FWP Abivax S.A. Filed by: Abivax S.A.

Wed, 01 Jul 2026 09:16:00 -0400

si-local-file:///var/storage/secattach/20260701/26717996.html

Abivax prices upsized $800M ADS offering at $125 per share